Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?

Company Performance - Rockwell Medical (RMTI) shares have increased by 83.1% over the past month, reaching a new 52-week high of $3.43 [1] - The stock has gained 71.4% since the beginning of the year, outperforming the Zacks Medical sector's 11.8% and the Zacks Medical - Products industry's 12.8% returns [1] Earnings and Revenue - Rockwell Medical has consistently exceeded earnings expectations, reporting an EPS of $0.01 against a consensus estimate of -$0.04 in its last earnings report [2] - The company beat the consensus revenue estimate by 12.26% in the same report [2] - For the current fiscal year, Rockwell Medical is projected to have earnings of -$0.03 per share on revenues of $98.8 million, reflecting an 82.35% change in EPS and an 18.16% change in revenues [3] - For the next fiscal year, expected earnings are $0.07 per share on revenues of $107.26 million, indicating a year-over-year change of 333.33% in EPS and 8.56% in revenues [3] Valuation Metrics - Rockwell Medical currently holds a Value Score of C, a Growth Score of A, and a Momentum Score of B, resulting in a VGM Score of A [6] - The stock has a Zacks Rank of 1 (Strong Buy) due to rising earnings estimates, suggesting potential for further gains [7][8] Industry Comparison - ICU Medical, Inc. (ICUI) is a notable peer in the industry, holding a Zacks Rank of 2 (Buy) with a Value Score of B, a Growth Score of C, and a Momentum Score of C [9] - ICU Medical reported earnings that exceeded consensus estimates by 59.18%, with projected earnings of $5.16 per share on revenues of $2.29 billion for the current fiscal year [10] - The Medical - Products industry is positioned in the top 37% of all industries, indicating favorable conditions for both RMTI and ICUI [11]